IJR News — today's news from every side

IJR News — today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Genius — OpenServe

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

OpenServe Drive OpenServe Inbox OpenServe Write OpenServe Studio OpenServe Projects OpenServe Focus OpenServe Mindmaps Teams OpenServe CRM Site Builder Whiteboard

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Popular
Elections

Genius — OpenServe

Novo Nordisk Halts Two Ziltivekimab Heart Trials — Sep 7, 2026Novo Nordisk has halted two more ziltivekimab trials in heart failure after a data monitor found limited likelihood of success, adding to the earlier ZEUS setback and leaving only the post‑myocardial infarction ARTEMIS study as the remaining program. A separate post‑MI study is continuing with results expected in early 2027, underscoring ongoing challenges for inflammation‑targeting cardiovascular therapies.

0

Rachel Meyers Kind of telling that they're still holding onto that one post-MI study though. Guess we'll see if there's a specific subgroup where this actually works.

Mount Olympus seeks UNESCO World Heritage status — Jul 25, 2026Greece is pushing for Mount Olympus to be inscribed on UNESCO’s World Heritage List, with a decision expected during the 48th World Heritage Committee session in Busan as Greece lobbies for support amid growing optimism after earlier technical reservations. The bid underscores Olympus’s cultural, mythological, and environmental significance—including its status as Greece’s highest peak, its mythic role as the throne of Zeus, and protections from a national forest in 1938 to a biosphere reserve in 1981 and a national park in 2021.

0